PE20030338A1 - Utilizacion de derivados de sistemas de indan-1-ol-sustituidos en c2 para la preparacion de medicamentos para la profilaxia o el tratamiento de la obesidad - Google Patents
Utilizacion de derivados de sistemas de indan-1-ol-sustituidos en c2 para la preparacion de medicamentos para la profilaxia o el tratamiento de la obesidadInfo
- Publication number
- PE20030338A1 PE20030338A1 PE2002000811A PE2002000811A PE20030338A1 PE 20030338 A1 PE20030338 A1 PE 20030338A1 PE 2002000811 A PE2002000811 A PE 2002000811A PE 2002000811 A PE2002000811 A PE 2002000811A PE 20030338 A1 PE20030338 A1 PE 20030338A1
- Authority
- PE
- Peru
- Prior art keywords
- obesity
- treatment
- prophylaxia
- drugs
- preparation
- Prior art date
Links
- 208000008589 Obesity Diseases 0.000 title abstract 3
- 235000020824 obesity Nutrition 0.000 title abstract 3
- 238000011282 treatment Methods 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 2
- -1 C2-substituted indan-1-ol compounds Chemical class 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2264—Obesity-gene products, e.g. leptin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Child & Adolescent Psychology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE REFIERE A UTILIZACION DE COMPUESTOS INDAN-1-OL-SUSTITUIDOS EN C2 DE FORMULA I DONDE R1, R2, R3, R4 SON H, F, Cl, Br, I, CN, N3, NO2, OH, O-ALQUILO C1-C8, O-CICLOALQUILO C3-C8, O-CH2-FENILO, O-FENILO, ENTRE OTROS; R2 Y R3 FORMAN JUNTOS O-CH2-O; X ES S, SO, SO2; Y ES (CH2)p; p ES 0-3; R5 ES CF3, ALQUILO C1-C8, CICLOALQUILO C3-C8, (CH2)rCOR6, CH2-CH(NHR7)-COR8, FENILO, r ES 1-6; R6 ES OH, O-ALQUILO C1-C6, NH2; R8 ES OH, O-ALQUILO C1-C6, NH2, R9 ES ALQUILO C1-C12, CICLOALQUILO, ENTRE OTROS; R10 ES ALQUILO C1-C12, CICLOALQUILO C3-C8, FENILO, ENTRE OTROS; R11 ES ALQUILO C1-C12, CICLOALQUILO C3-C8; R12 ES H, ALQUILO C1-C6 PARA EL TRATAMIENTO DE OBESIDAD. TAMBIEN SE REFIERE AL USO CON CATINAS, FENILPROPANOLAMINAS, AMFEPRAMONA, MEFENOREX, EFEDRINA, LEPTINA, DEXANFETAMINA, ANFETAMINA, FENFLURAMINA, ENTRE OTROS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10142660A DE10142660A1 (de) | 2001-08-31 | 2001-08-31 | Verwendung von Derivaten von C2-substituierten Indan-1-ol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20030338A1 true PE20030338A1 (es) | 2003-05-23 |
Family
ID=7697231
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2002000811A PE20030338A1 (es) | 2001-08-31 | 2002-08-23 | Utilizacion de derivados de sistemas de indan-1-ol-sustituidos en c2 para la preparacion de medicamentos para la profilaxia o el tratamiento de la obesidad |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US6667345B2 (es) |
| EP (1) | EP1424985B1 (es) |
| JP (1) | JP2005501879A (es) |
| AT (1) | ATE385792T1 (es) |
| AU (1) | AU2002342615B2 (es) |
| CA (1) | CA2458552A1 (es) |
| DE (2) | DE10142660A1 (es) |
| IL (1) | IL160601A0 (es) |
| MX (1) | MXPA04001858A (es) |
| PE (1) | PE20030338A1 (es) |
| WO (1) | WO2003020199A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10142666A1 (de) * | 2001-08-31 | 2003-03-20 | Aventis Pharma Gmbh | Verwendung von C2-substituierten Indan-1-ol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas |
| DE10142663B4 (de) | 2001-08-31 | 2004-08-19 | Aventis Pharma Deutschland Gmbh | C2-Disubstituierte Indan-1-ol-Systeme |
| WO2004101505A1 (en) * | 2003-05-14 | 2004-11-25 | Novo Nordisk A/S | Novel compounds for treatment of obesity |
| WO2005051900A1 (en) * | 2003-11-25 | 2005-06-09 | Novo Nordisk A/S | Novel compounds for the treatment of obesity |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2965279D1 (en) * | 1978-07-27 | 1983-06-01 | Schering Ag | Indanyl derivatives, process for their preparation and pharmaceutical compositions containing these compounds |
| AU1169397A (en) * | 1995-12-06 | 1997-06-27 | Venantius Limited | Indane compounds with smooth muscle relaxing and/or mast cell stabilising and/or anti-inflammatory activity |
| WO1997026265A1 (en) | 1996-01-17 | 1997-07-24 | Novo Nordisk A/S | Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
| DK0944648T3 (da) | 1996-08-30 | 2007-07-02 | Novo Nordisk As | GLP-1 derivater |
| RU2200161C2 (ru) | 1996-12-31 | 2003-03-10 | Др. Редди'З Рисерч Фаундейшн | Новые производные азолидиндиона, способ их получения (варианты), фармацевтические композиции на их основе, способ предупреждения или лечения, способ снижения глюкозы и промежуточное соединение |
| CA2294830A1 (en) | 1997-07-16 | 1999-01-28 | John Bondo Hansen | Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| US5987946A (en) | 1997-08-15 | 1999-11-23 | Watts; James A. | Lock picking method and apparatus |
| FR2796070B1 (fr) * | 1999-07-06 | 2003-02-21 | Lipha | Derives de benzodiazepines utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procedes de preparation |
| EP1078632A1 (en) | 1999-08-16 | 2001-02-28 | Sanofi-Synthelabo | Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity |
| CA2400698A1 (en) * | 2000-02-23 | 2001-08-30 | Aventis Pharma Deutschland Gmbh | 8,8a-dihydro-indeno[1,2-d]thiazole derivatives, substituted in position 8a, a method for their production and their use as medicaments, e.g. anorectic agents |
| DE10142662B4 (de) * | 2001-08-31 | 2004-07-08 | Aventis Pharma Deutschland Gmbh | Derivate von C2-substituierten Indan-1-ol-Systemen und ihre Verwendung als Arzneimittel |
-
2001
- 2001-08-31 DE DE10142660A patent/DE10142660A1/de not_active Withdrawn
-
2002
- 2002-08-17 IL IL16060102A patent/IL160601A0/xx unknown
- 2002-08-17 CA CA002458552A patent/CA2458552A1/en not_active Abandoned
- 2002-08-17 DE DE50211693T patent/DE50211693D1/de not_active Expired - Lifetime
- 2002-08-17 JP JP2003524513A patent/JP2005501879A/ja not_active Withdrawn
- 2002-08-17 AT AT02779265T patent/ATE385792T1/de not_active IP Right Cessation
- 2002-08-17 EP EP02779265A patent/EP1424985B1/de not_active Expired - Lifetime
- 2002-08-17 AU AU2002342615A patent/AU2002342615B2/en not_active Ceased
- 2002-08-17 WO PCT/EP2002/009199 patent/WO2003020199A1/de active IP Right Grant
- 2002-08-17 MX MXPA04001858A patent/MXPA04001858A/es active IP Right Grant
- 2002-08-23 PE PE2002000811A patent/PE20030338A1/es not_active Application Discontinuation
- 2002-08-29 US US10/230,379 patent/US6667345B2/en not_active Expired - Lifetime
-
2003
- 2003-10-27 US US10/692,725 patent/US6919380B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| IL160601A0 (en) | 2004-07-25 |
| EP1424985B1 (de) | 2008-02-13 |
| US6919380B2 (en) | 2005-07-19 |
| MXPA04001858A (es) | 2004-06-15 |
| ATE385792T1 (de) | 2008-03-15 |
| EP1424985A1 (de) | 2004-06-09 |
| US6667345B2 (en) | 2003-12-23 |
| US20030134881A1 (en) | 2003-07-17 |
| JP2005501879A (ja) | 2005-01-20 |
| US20040092748A1 (en) | 2004-05-13 |
| DE50211693D1 (de) | 2008-03-27 |
| CA2458552A1 (en) | 2003-03-13 |
| DE10142660A1 (de) | 2003-03-20 |
| WO2003020199A1 (de) | 2003-03-13 |
| AU2002342615B2 (en) | 2006-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03005464A (es) | Agentes antivirales. | |
| GB0022438D0 (en) | Organic Compounds | |
| CU23208A3 (es) | Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea | |
| GB0112348D0 (en) | Compounds | |
| NO20055649L (no) | Substituert dihydrokinazolin med antiviale egenskaper | |
| DE60205455T2 (de) | Naphthyridinderivate | |
| BRPI0515860A (pt) | derivados de tetralin e indano, e uso dos mesmos | |
| DK1124841T3 (da) | Substituerede phenylalkenoylguanidiner, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemidler eller diagnosemidler og lægemidler, som indeholder dem | |
| MXPA04001847A (es) | Uso de sistemas de indan-1-ol polisbstituidos para producir drogas utilizadas en la profilaxis o tratamiento de la obesidad. | |
| EE05241B1 (et) | Distamtsiini a-halogenoakrlolderivaadi kasutamine | |
| PE20030338A1 (es) | Utilizacion de derivados de sistemas de indan-1-ol-sustituidos en c2 para la preparacion de medicamentos para la profilaxia o el tratamiento de la obesidad | |
| BR0008519A (pt) | Aplicação de sistemas tiazol policìclicos para apreparação de medicamentos para a profilaxia outratamento da obesidade | |
| PE20030335A1 (es) | Utilizacion de sistemas de indan-1-ol-sustituidos en c2 para la preparacion de medicamentos para la profilaxia o el tratamiento de la obesidad | |
| IL160603A0 (en) | C2-disubstituted indan-1-ol systems and their derivatives, processes for their preparation and their use as pharmaceuticals | |
| IL160604A0 (en) | C2-disubstituted indan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals | |
| BRPI0415546A (pt) | composto, composição farmacêutica, uso de um composto, e, métodos de tratamento ou profilaxia de doenças ou condições humanas, e de distúrbios | |
| MXPA04001853A (es) | Uso de sistemas de indan-1-ona c2-substituida para producir medicamentos para la profilaxis o tratamiento de obesidad. | |
| PT1490049E (pt) | Citalopram para o tratamento da pre3ssao sanguinia elevada. | |
| PE20030364A1 (es) | Sistemas de indan-1-ol varias veces sustituidos y procedimiento para su preparacion | |
| NO20072091L (no) | Forbindelser, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav III | |
| DOP2001000253A (es) | Alcanosulfonatos de fenoxifenilo. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |